Repaglinide and Metformin Hydrochloride (Lupin Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Repaglinide and Metformin Hydrochloride drug offered from Lupin Pharmaceuticals, Inc.. This Biguanide [EPC],Biguanides [Chemical/Ingredient],Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lupin Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Repaglinide and Metformin Hydrochloride |
| SUBSTANCE NAME: | METFORMIN HYDROCHLORIDE; REPAGLINIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Biguanide [EPC],Biguanides [Chemical/Ingredient],Glinide [EPC],Potassium Channel Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-12-10 |
| END MARKETING DATE: | 0000-00-00 |
Repaglinide and Metformin Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Repaglinide and Metformin Hydrochloride from Lupin Pharmaceuticals, Inc. |
| LABELER NAME: | Lupin Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500; 1(mg/1; mg/1) |
| START MARKETING DATE: | 2015-12-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68180-490_38227aca-9f9d-4452-ba2b-305abaa1c020 |
| PRODUCT NDC: | 68180-490 |
| APPLICATION NUMBER: | ANDA200624 |
Other METFORMIN HYDROCHLORIDE; REPAGLINIDE Pharmaceutical Manufacturers / Labelers:
